Fragment Optimization

Fragment Optimization is a methodological process in drug discovery that involves the systematic enhancement of weak-binding molecular fragments into potent lead compounds through iterative structural modification and affinity improvement.

185

Publications

12.3K

Citations

1.4K

Authors

304

Institutions

Publications per year

2017–2026

70

Authors

1.4K

  1. MC
    Miles Congreve

    Heptares Therapeutics (United Kingdom), United Kingdom

    6 publications · 942 citations

    6

    h-index

  2. IJ
    Iwan J. P. de Esch

    Vrije Universiteit Amsterdam, Netherlands

    5 publications · 500 citations

    5

    h-index

  3. MF
    Martyn Frederickson

    University of Leeds, United Kingdom

    5 publications · 896 citations

    5

    h-index

  4. CW
    Christopher W. Murray

    Proteus (United Kingdom), United Kingdom

    5 publications · 1.1K citations

    5

    h-index

  5. PN
    Paul N. Mortenson

    GlaxoSmithKline (United States), United States

    5 publications · 253 citations

    5

    h-index

1–5 of 1.4K

Venues

  1. Journal of Medicinal Chemistry

    51 publications · 4.1K citations

    35

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    11 publications · 305 citations

    11

    h-index

  3. ACS Medicinal Chemistry Letters

    10 publications · 290 citations

    10

    h-index

  4. ChemMedChem

    8 publications · 252 citations

    8

    h-index

  5. Bioorganic & Medicinal Chemistry

    7 publications · 235 citations

    7

    h-index

1–5